CAS No |
Product Name |
Molecular Formula |
1421372-67-9
|
N1-(2-(Dimethylamino)ethyl)-5-methoxy-N1-methyl-N4-(4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)-2-nitro-1,4-benzenediamine
|
C25H29N7O3
|
1421372-94-2
|
N-(4-Fluoro-2-methoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)-2-pyrimidinamine
|
C20H16FN5O3
|
1421373-36-5
|
3-Chloro-N-(2-((2-(dimethylamino)ethyl)methylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)amino)phenyl)propanamide
|
C28H34ClN7O2
|
1421373-62-7
|
N-(5-((5-Chloro-4-(1H-indol-3-yl)-2-pyrimidinyl)amino)-2-((2-(dimethylamino)ethyl)methylamino)-4-methoxyphenyl)-2-propenamide;Mutant EGFR inhibitor
|
C27H30ClN7O2
|
1421373-65-0
|
N-(2-((2-(Dimethylamino)ethyl)methylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)amino)phenyl)-2-propenamide;osimertinib
|
C28H33N7O2
|
1421373-66-1
|
AZD-9291 mesylate;N-(2-((2-(Dimethylamino)ethyl)methylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)amino)phenyl)-2-propenamide methanesulfonate (1:1)
|
C28H33N7O2.CH4O3S
|
1421373-98-9
|
N-(2-((2-(Dimethylamino)ethyl)methylamino)-5-((4-(1H-indol-3-yl)-2-pyrimidinyl)amino)-4-methoxyphenyl)-2-propenamide
|
C27H31N7O2
|
1421374-01-7
|
5-Methyl-2,5-diazaspiro(3.4)octane
|
C7H14N2
|
1421438-81-4
|
N-((1S)-2-(((7S)-6,7-Dihydro-5-(2-hydroxyethyl)-6-oxo-5H-pyrido(3,2-a)(3)benzazepin-7-yl)amino)-1-methyl-2-oxoethyl)-4,4,4-trifluorobutanamide
|
C22H23F3N4O4
|
1421593-80-7
|
N-Acetyl Lenalidomide;N-(2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl)acetamide
|
C15H15N3O4
|
1421599-34-9
|
4-(1,1'-Biphenyl)-4-yl-6-(4-bromophenyl)-2-phenylpyrimidine
|
C28H19BrN2
|
1421602-80-3
|
2,4-Dibromo-6-fluoro-3-pyridinol
|
C5H2Br2FNO
|
1421783-64-3
|
GZD 824;4-Methyl-N-(4-((4-methyl-1-piperazinyl)methyl)-3-(trifluoromethyl)phenyl)-3-(2-(1H-pyrazolo(3,4-b)pyridin-5-yl)ethynyl)benzamide methanesulfonate (1:2)
|
C29H27F3N6O.2(CH4O3S)
|
1421789-05-0
|
9,9'-Spirobi(9H-fluoren)-4-ylboronic acid
|
C25H17BO2
|
1421789-94-7
|
2-(Bromomethyl)pyrazine hydrobromide (1:1)
|
C5H5BrN2.HBr
|
1421846-79-8
|
3-Methylisoxazole-4-boronic acid pinacol ester;3-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoxazole
|
C10H16BNO3
|
1421919-75-6
|
(2Z)-3-(3-(3,5-Bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-1-(3,3-difluoro-1-azetidinyl)-2-propen-1-one
|
C16H10F8N4O
|
1421923-86-5
|
(2E)-3-(3-(3,5-Bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-2-propenoic acid 2-(2-pyrazinyl)hydrazide
|
C17H11F6N7O
|
1422144-42-0
|
2,4-Dimethylbenzoic acid (4-((1S)-1-(aminomethyl)-2-(6-isoquinolinylamino)-2-oxoethyl)phenyl)methyl ester methanesulfonate (1:2)
|
C28H27N3O3.2(CH4O3S)
|
1422284-15-8
|
(8R)-9-(6-Amino-9H-purin-9-yl)-8-methyl-5-(1-methylethoxy)-2,4,7-trioxa-5-phosphanonanoic acid 1-methylethyl ester 5-oxide 2-butenedioate (1:1)
|
C17H28N5O7P.C4H4O4
|
1422357-33-2
|
Rotigotine EP Impurity G;(6S)-6-(bis(2-thiophen-2-ylethyl)amino)-5,6,7,8-tetrahydronaphthalen-1-ol
|
C22H25NOS2
|
1422359-85-0 / 136379-59-4
|
Fumonisin B3
|
C34H59NO14
|
1422500-60-4
|
Ziresovir;N-((3-aminooxetan-3-yl)methyl)-2-(1,1-dioxo-3,5-dihydro-2H-1?6,4-benzothiazepin-4-yl)-6-methylquinazolin-4-amine
|
C22H25N5O3S
|
1422515-52-3
|
Fexofenadine N-Oxide;1-(4-(4-(2-Carboxypropan-2-yl)phenyl)-4-hydroxybutyl)-4-(hydroxydiphenylmethyl)piperidine 1-oxide
|
C32H39NO5
|
1422619-13-3
|
(3R,6E)-7-(4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl)amino)-5-pyrimidinyl)-3-hydroxy-5-oxo-6-heptenoic acid
|
C22H26FN3O6S
|
1422954-11-7
|
Rosuvastatin (3R,5R)-Lactone;(3R,5R)-Rosuvastatin Lactone;N-(4-(4-fluorophenyl)-5-((E)-2-((2R,4R)-4-hydroxy-6-oxooxan-2-yl)ethenyl)-6-propan-2-ylpyrimidin-2-yl)-N-methylmethanesulfonamide
|
C22H26FN3O5S
|
1422956-31-7
|
5-(1-Piperazinyl)-2-benzofurancarboxylic acid ethyl ester dihydrochloride hydrate
|
C15H18N2O3.2(HCl).H2O
|
1423018-01-2
|
Ethyl thio-beta-D-galactopyranoside 2,4,6-tribenzoate
|
C29H28O8S
|
1423030-14-1
|
(Z)-3-(3-Bromo-4-fluorobenzylidene)isobenzofuran-1(3H)-one
|
C15H8BrFO2
|
1423715-09-6
|
3-(4-Morpholinylsulfonyl)benzoic acid (2E)-2-(1-(5-chloro-2-hydroxyphenyl)ethylidene)hydrazide
|
C19H20ClN3O5S
|
1424245-91-9
|
7-Chloro-3-iodoquinoline
|
C9H5ClIN
|
1424245-96-4
|
3-Iodo-8-methylquinoline
|
C10H8IN
|
1424858-02-5
|
Aripiprazole Impurity 47;7,7'-((Oxybis(butane-4,1-diyl))bis(oxy))bis(3,4-dihydroquinolin-2(1H)-one)
|
C26H32N2O5
|
1425038-21-6
|
(S)-3,3-Dimethyl-2-((((1R,2R)-2-(pent-4-yn-1-yl)cyclopropoxy)carbonyl)amino)butyric acid tert-butylamine salt;3-Methyl-N-((((1R,2R)-2-(4-pentyn-1-yl)cyclopropyl)oxy)carbonyl)-L-valine compd. with 2-methyl-2-propanamine
|
C15H23NO4.C4H11N
|
1425254-01-8
|
(1S,3R)-(3-Hydroxy-cyclohexyl)-carbamic acid tert-butyl ester
|
C11H21NO3
|
1425485-72-8
|
DBCO-C6-acid;6-(2-azatricyclo(10.4.0.04,9)hexadeca-1(16),4,6,8,12,14-hexaen-10-yn-2-yl)-6-oxohexanoic acid
|
C21H19NO3
|
1425927-75-8
|
6-Amino-1,3-dimethyl-1H-quinolin-2-one;6-Amino-1,3-dimethyl-2(1H)-quinolinone
|
C11H12N2O
|
1425931-95-8
|
5-(3,3-Difluorocyclobutyl)-1H-pyrazol-3-amine
|
C7H9F2N3
|
1425938-63-1
|
(4S)-3-((2S,3R)-3-(1,1-Dimethylethoxy)-2-(((9H-fluoren-9-ylmethoxy)carbonyl)amino)-1-oxobutyl)-2,2-dimethyl-4-oxazolidinecarboxylic acid
|
C29H36N2O7
|
1426129-50-1
|
N-((1R)-2-(1,1'-Biphenyl)-4-yl-1-(hydroxymethyl)ethyl)carbamic acid 1,1-dimethylethyl ester
|
C20H25NO3
|
1426135-66-1
|
5,5-Difluorooxane-2-carboxylic acid
|
C6H8F2O3
|
1426138-42-2
|
(5Z)-5-(5-Chloro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)-4-oxo-2-thioxo-3-thiazolidinepropanoic acid
|
C14H9ClN2O4S2
|
1426173-86-5
|
Silodosin-d4;1-(3-hydroxypropyl)-5-((2R)-2-((1,1,2,2-tetradeuterio-2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethyl)amino)propyl)-2,3-dihydroindole-7-carboxamide
|
C25D4H28F3N3O4
|
1426290-08-5
|
5-Bromo-2-chloro-4-fluorophenylacetonitrile;2-(5-bromo-2-chloro-4-fluorophenyl)acetonitrile
|
C8H4BrClFN
|
1426566-90-6
|
4-Bromo-3-chloro-2-iodobenzenamine
|
C6H4BrClIN
|
1426821-11-5
|
(2E)-2-Cyano-2-((((1,1-dimethylethoxy)carbonyl)oxy)imino)acetic acid ethyl ester
|
C10H14N2O5
|
1426944-49-1
|
9-Chloro-5,6,7,8-tetrahydro-N-(3-(methyl(phenylmethyl)amino)propyl)-2-acridinecarboxamide;HBX 19818
|
C25H28ClN3O
|
1426953-21-0
|
Thailanstatin A;2-((3R,4R,5R,7S)-5-((1E,3E)-5-((2S,3S,5R,6R)-5-(((Z,4S)-4-acetyloxypent-2-enoyl)amino)-3,6-dimethyloxan-2-yl)-3-methylpenta-1,3-dienyl)-4-hydroxy-1,6-dioxaspiro(2.5)octan-7-yl)acetic acid
|
C28H41NO9
|
1426960-33-9
|
MK 8876;2-(4-Fluorophenyl)-5-(11-fluoro-6H-pyrido(2',3':5,6)(1,3)oxazino(3,4-a)indol-2-yl)-N-methyl-6-(methyl(methylsulfonyl)amino)-3-benzofurancarboxamide
|
C32H24F2N4O5S
|
1427004-19-0
|
2,5-Dioxo-1-pyrrolidinyl 20-(11,12-didehydrodibenz(b,f)azocin-5(6H)-yl)-17,20-dioxo-4,7,10,13-tetraoxa-16-azaeicosanoate;DBCO-PEG4-NHS; DBCO-PEG4-NHS Ester; NHS-PEG4-DBCO
|
C34H39N3O10
|